Edition:
United States

Soleno Therapeutics Inc (SLNO.OQ)

SLNO.OQ on NASDAQ Stock Exchange Capital Market

1.74USD
18 Jan 2019
Change (% chg)

$-0.01 (-0.57%)
Prev Close
$1.75
Open
$1.76
Day's High
$1.80
Day's Low
$1.70
Volume
6,725
Avg. Vol
13,179
52-wk High
$3.60
52-wk Low
$1.49

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.108
Jun '18 0.00 -0.355
Mar '18 0.00 -0.166
FY 2017 Dec '17 0.00 0.674
Sep '17 0.00 -0.258
Jun '17 0.00 -0.321
Mar '17 0.00 -0.241
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Quarter Ending Jun-19 1 0.00 0.00 0.00 --
Year Ending Dec-19 2 0.75 1.50 0.00 1.50
Earnings (per share)
Quarter Ending Mar-19 1 -0.30 -0.30 -0.30 --
Quarter Ending Jun-19 1 -0.27 -0.27 -0.27 --
Year Ending Dec-19 1 -0.74 -0.74 -0.74 -0.92
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 22.84 30.69 30.88
P/E High - Last 5 Yrs. -- 39.16 46.69
P/E Low - Last 5 Yrs. -- 23.61 25.78
Beta 4.19 0.77 0.95
Price to Sales (TTM) -- 5.95 21.76
Price to Book (MRQ) 3.17 4.48 4.53
Price to Tangible Book (MRQ) -- 7.83 11.76
Price to Cash Flow (TTM) -- 23.09 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.08 1.60
Dividend Yield - 5 Year Avg -- 1.16 1.42
Dividend 5 Year Growth Rate -- 15.29 -8.76
Payout Ratio(TTM) -- 30.61 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.72 6.54
Sales (TTM) vs TTM 1 Yr. Ago -100.00 8.29 5.26
Sales - 5 Yr. Growth Rate -- 9.55 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 58.19 -6.09 22.50
EPS (TTM) vs TTM 1 Yr. Ago 103.81 -- --
EPS - 5 Yr. Growth Rate -- 14.46 7.64
Capital Spending - 5 Yr. Growth Rate 0.63 5.23 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.31 2.63
Current Ratio (MRQ) 4.55 2.99 3.68
LT Debt to Equity (MRQ) 0.00 20.53 9.53
Total Debt to Equity (MRQ) 0.00 26.54 13.39
Interest Coverage (TTM) -- 18.59 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 58.51 50.91
Gross Margin - 5 Yr. Avg. -- 57.92 52.22
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -949.36 23.57 16.27
Operating Margin (TTM) -- 18.16 -15.11
Operating Margin - 5 Yr. Avg. -1,071.71 16.26 11.89
Pre-Tax Margin (TTM) -- 17.65 -13.67
Pre-Tax Margin - 5 Yr. Avg. -1,495.57 16.21 12.22
Net Profit Margin (TTM) -- 14.05 -17.11
Net Profit Margin - 5 Yr. Avg. -1,155.62 11.55 8.44
Effective Tax Rate (TTM) -- 19.42 21.73
Effective Tax Rate - 5 Yr. Avg. -- 27.38 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 30,726,224 878,349,382
Net Income/Employee (TTM) -- 3,334,701 102,474,711
Receivable Turnover (TTM) -- 5.05 5.49
Inventory Turnover (TTM) -- 3.28 3.99
Asset Turnover (TTM) 0.00 0.75 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -21.33 10.26 11.06
Return on Assets - 5 Yr. Avg. -93.65 8.99 11.85
Return on Investment (TTM) -23.04 12.93 13.80
Return on Investment - 5 Yr. Avg. -238.07 11.63 15.17
Return on Equity (TTM) -32.62 15.64 15.29
Return on Equity - 5 Yr. Avg. -- 14.19 16.29
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 95.14 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Soleno Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 59.53%
# of Holders: 26
Total Shares Held: 12,761,336
3 Mo. Net Change: 7,538
# New Positions: 5
# Closed Positions: 4
# Increased Positions: 12
# Reduced Positions: 8
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.